![Prakash Gowd](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Prakash Gowd
Direktor/Vorstandsmitglied bei
APPILI THERAPEUTICS INC.
Vermögen: - $ am 31.05.2026
Profil
Prakash Gowd was the founder of Lobo Genetics, Inc., founded in 2018, and served as President from 2018 to 2021.
Current jobs include Independent Director at BioSyent, Inc. starting in 2025, Director at HDAX Therapeutics, Inc., Independent Director at Appili Therapeutics, Inc. starting in 2023, and Vice President at Toronto Innovation Acceleration Partners starting in 2023.
Former jobs include Chief Executive Officer at InDanio Bioscience, Inc., Independent Non-Executive Director at Isotechnika Pharma, Inc. from 2010 to 2013, Managing Director at Kilmer Lucas, Inc., Director at FendX Technologies, Inc. from 2021 to 2022, Research Analyst at Canaccord Adams, Analyst at CIBC World Markets, Inc., Research Analyst at National Bank Financial, Inc. (Broker), and Chief Operating Officer at Novamind, Inc. from 2022 to 2023.
Education includes an MBA degree from McGill University conferred in 1992 and undergraduate studies at the University of British Columbia.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 30.06.2025 | 0 ( -.--% ) | - $ | 31.05.2026 |
Aktive Positionen von Prakash Gowd
| Unternehmen | Position | Beginn |
|---|---|---|
| APPILI THERAPEUTICS INC. | Direktor/Vorstandsmitglied | 13.11.2023 |
| BIOSYENT INC. | Direktor/Vorstandsmitglied | 15.05.2025 |
Toronto Innovation Acceleration Partners
 Toronto Innovation Acceleration Partners BiotechnologyHealth Technology Operates as a commercialization agent | Corporate Officer/Principal | 01.12.2023 |
Hdax Therapeutics, Inc.
 Hdax Therapeutics, Inc. Packaged SoftwareTechnology Services Develops drug discovery platform intended for the treatment of HDAC-driven pathologies | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Prakash Gowd
| Unternehmen | Position | Ende |
|---|---|---|
| NOVAMIND INC. | Geschäftsführer | 01.08.2023 |
| FENDX TECHNOLOGIES INC. | Direktor/Vorstandsmitglied | 05.12.2022 |
Lobo Genetics, Inc.
 Lobo Genetics, Inc. Agricultural Commodities/MillingProcess Industries Engages in cannabis business for healthcare | Gründer | 01.06.2021 |
Isotechnika Pharma, Inc.
 Isotechnika Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company, which focuses on discovery and development of immunomodulating therapeutics | Direktor/Vorstandsmitglied | 23.10.2013 |
National Bank Financial, Inc. (Broker)
 National Bank Financial, Inc. (Broker) Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 30.03.2008 |
Ausbildung von Prakash Gowd
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
77
Beziehungen ersten Grades
15
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 15 |
|---|---|
BioSyent, Inc.
 BioSyent, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical products | Health Technology |
Canaccord Adams
 Canaccord Adams Investment Banks/BrokersFinance Provides brokerage services | Finance |
CIBC World Markets, Inc.
 CIBC World Markets, Inc. Investment Banks/BrokersFinance Provides brokerage services | Finance |
National Bank Financial, Inc. (Broker)
National Bank Financial, Inc. (Broker) Investment Banks/BrokersFinance Provides brokerage services | Finance |
McGill University
 McGill University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of British Columbia
 University of British Columbia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Isotechnika Pharma, Inc.
Isotechnika Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company, which focuses on discovery and development of immunomodulating therapeutics | Health Technology |
Toronto Innovation Acceleration Partners
Toronto Innovation Acceleration Partners BiotechnologyHealth Technology Operates as a commercialization agent | Health Technology |
Kilmer Lucas, Inc.
 Kilmer Lucas, Inc. Investment ManagersFinance Provides investor relations, public relations, and strategic advisory services | Finance |
InDanio Bioscience, Inc.
 InDanio Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Engages in drug discovery | Health Technology |
Appili Therapeutics, Inc.
 Appili Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals for infectious disease | Health Technology |
Lobo Genetics, Inc.
Lobo Genetics, Inc. Agricultural Commodities/MillingProcess Industries Engages in cannabis business for healthcare | Process Industries |
Novamind, Inc.
 Novamind, Inc. Medical/Nursing ServicesHealth Services Provides investment services in infrastructure of psychedelic clinics and retreats | Health Services |
FendX Technologies, Inc.
 FendX Technologies, Inc. Industrial SpecialtiesProcess Industries Engages in manufacturing, research, development and distribution of surface protection products | Process Industries |
Hdax Therapeutics, Inc.
Hdax Therapeutics, Inc. Packaged SoftwareTechnology Services Develops drug discovery platform intended for the treatment of HDAC-driven pathologies | Technology Services |
